Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Epidemiological and clinical features of the 2019 novel coronavirus outbreak in China

Yang Yang, Qing-Bin Lu, Ming-Jin Liu, Yi-Xing Wang, An-Ran Zhang, Neda Jalali, Natalie E. Dean, Ira Longini, M. Elizabeth Halloran, Bo Xu, Xiao-Ai Zhang, Li-Ping Wang, Wei Liu, Li-Qun Fang
doi: https://doi.org/10.1101/2020.02.10.20021675
Yang Yang
1Department of Biostatistics, College of Public Health and Health Professions, and Emerging Pathogens Institute, University of Florida, Gainesville, Florida, U. S. A
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: fang_lq@163.com lwbime@163.com yangyang@ufl.edu wanglp@chinacdc.cn
Qing-Bin Lu
2Department of Laboratorial Science and Technology, School of Public Health, Peking University, Beijing, P. R. China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ming-Jin Liu
1Department of Biostatistics, College of Public Health and Health Professions, and Emerging Pathogens Institute, University of Florida, Gainesville, Florida, U. S. A
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yi-Xing Wang
3State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, P. R. China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
An-Ran Zhang
1Department of Biostatistics, College of Public Health and Health Professions, and Emerging Pathogens Institute, University of Florida, Gainesville, Florida, U. S. A
3State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, P. R. China
4Department of Epidemiology, School of Public Health, Shandong University, Jinan, P. R. China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Neda Jalali
1Department of Biostatistics, College of Public Health and Health Professions, and Emerging Pathogens Institute, University of Florida, Gainesville, Florida, U. S. A
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Natalie E. Dean
1Department of Biostatistics, College of Public Health and Health Professions, and Emerging Pathogens Institute, University of Florida, Gainesville, Florida, U. S. A
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ira Longini
1Department of Biostatistics, College of Public Health and Health Professions, and Emerging Pathogens Institute, University of Florida, Gainesville, Florida, U. S. A
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. Elizabeth Halloran
5Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, U. S. A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bo Xu
6Army Engineering University of PLA, Nanjing, P.R. China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xiao-Ai Zhang
3State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, P. R. China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Li-Ping Wang
7Division of Infectious Disease, Key Laboratory of Surveillance and Early-warning on Infectious Disease, Chinese Centre for Disease Control and Prevention
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: fang_lq@163.com lwbime@163.com yangyang@ufl.edu wanglp@chinacdc.cn
Wei Liu
3State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, P. R. China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: fang_lq@163.com lwbime@163.com yangyang@ufl.edu wanglp@chinacdc.cn
Li-Qun Fang
3State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, P. R. China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: fang_lq@163.com lwbime@163.com yangyang@ufl.edu wanglp@chinacdc.cn
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background The ongoing outbreak of the 2019 novel coronavirus (2019-nCoV) in China has led to the declaration of Public Health Emergency of International Concern by the World Health Organization.

Methods All 2019-nCoV infected patients reported to Chinese Center for Disease Control and Prevention up to 26 January 2020 were included for analysis. Disease and death incidence were compared between demographic groups and baseline conditions. Case fatality rates (CFRs) and the basic reproductive number R0 was estimated with a transmission model.

Results As of 26 January 2020, a total of 8866 patients including 4021 (45.35%) laboratory confirmed patients were reported from 30 provinces. Nearly half of the patients were aged 50 years or older (47.7%). There was a clear gender difference in incidence with 0.31 (male) vs. 0.27 (female) per 100,000 people (P<0.001). The median incubation period was 4.75 (interquartile range: 3.0-7.2) days. About 25.5%, 69.9% and 4.5% patients were diagnosed with severe pneumonia, mild pneumonia, and non-pneumonia, respectively. The overall CFR was estimated be 3.06% (95% CI 2.02-4.59%), but male patients, ≥60 years old, baseline diagnosis of severe pneumonia and delay in diagnosis were associated with substantially elevated CFR. The R0 was estimated to be 3.77 (95% CI 3.51-4.05), ranging 2.23-4.82 in sensitivity analyses varying the incubation and infectious periods.

Conclusions Compared with SARS-CoV, 2019-nCoV had comparable transmissibility and lower CFR. Our findings based on individual-level surveillance data emphasize the importance of early detection of elderly patients, particularly males, before symptoms progress to severe pneumonia.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was financially supported by grants from the China Mega-Project on Infectious Disease Prevention (No. 2018ZX10713001, 2018ZX10713002, 2017ZX10103004 and 2018ZX10101003-002), the National Natural Science Funds (No. 81825019), and the U.S. National Institute of Health (R01 AI139761 and R01 AI116770).

Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Request for individual case data should be directed to Chinese Center for Disease Control and Prevention. Summary data used for tables and figures in this manuscript can be requested by emailing the corresponding authors.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted February 11, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Epidemiological and clinical features of the 2019 novel coronavirus outbreak in China
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Epidemiological and clinical features of the 2019 novel coronavirus outbreak in China
Yang Yang, Qing-Bin Lu, Ming-Jin Liu, Yi-Xing Wang, An-Ran Zhang, Neda Jalali, Natalie E. Dean, Ira Longini, M. Elizabeth Halloran, Bo Xu, Xiao-Ai Zhang, Li-Ping Wang, Wei Liu, Li-Qun Fang
medRxiv 2020.02.10.20021675; doi: https://doi.org/10.1101/2020.02.10.20021675
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Epidemiological and clinical features of the 2019 novel coronavirus outbreak in China
Yang Yang, Qing-Bin Lu, Ming-Jin Liu, Yi-Xing Wang, An-Ran Zhang, Neda Jalali, Natalie E. Dean, Ira Longini, M. Elizabeth Halloran, Bo Xu, Xiao-Ai Zhang, Li-Ping Wang, Wei Liu, Li-Qun Fang
medRxiv 2020.02.10.20021675; doi: https://doi.org/10.1101/2020.02.10.20021675

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (280)
  • Allergy and Immunology (579)
  • Anesthesia (140)
  • Cardiovascular Medicine (1950)
  • Dentistry and Oral Medicine (253)
  • Dermatology (185)
  • Emergency Medicine (333)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (702)
  • Epidemiology (11114)
  • Forensic Medicine (8)
  • Gastroenterology (628)
  • Genetic and Genomic Medicine (3189)
  • Geriatric Medicine (309)
  • Health Economics (563)
  • Health Informatics (2046)
  • Health Policy (864)
  • Health Systems and Quality Improvement (783)
  • Hematology (310)
  • HIV/AIDS (682)
  • Infectious Diseases (except HIV/AIDS) (12733)
  • Intensive Care and Critical Care Medicine (708)
  • Medical Education (317)
  • Medical Ethics (92)
  • Nephrology (336)
  • Neurology (2996)
  • Nursing (165)
  • Nutrition (465)
  • Obstetrics and Gynecology (589)
  • Occupational and Environmental Health (614)
  • Oncology (1559)
  • Ophthalmology (478)
  • Orthopedics (185)
  • Otolaryngology (266)
  • Pain Medicine (202)
  • Palliative Medicine (57)
  • Pathology (403)
  • Pediatrics (914)
  • Pharmacology and Therapeutics (382)
  • Primary Care Research (355)
  • Psychiatry and Clinical Psychology (2793)
  • Public and Global Health (5604)
  • Radiology and Imaging (1096)
  • Rehabilitation Medicine and Physical Therapy (635)
  • Respiratory Medicine (763)
  • Rheumatology (340)
  • Sexual and Reproductive Health (312)
  • Sports Medicine (289)
  • Surgery (346)
  • Toxicology (48)
  • Transplantation (159)
  • Urology (133)